How long should allopurinol be continued as maintenance therapy in a patient with gouty arthritis whose serum uric acid is already at target normal levels?

Continue Allopurinol Indefinitely

You should continue allopurinol indefinitely, even though your uric acid level is now at target. Stopping urate-lowering therapy after achieving normal uric acid levels leads to disease recurrence in the vast majority of patients 1.

Why Lifelong Treatment is Necessary

The 2020 American College of Rheumatology guidelines conditionally recommend continuing ULT indefinitely over stopping ULT 1. This recommendation is based on critical evidence showing that:

• When allopurinol was stopped in patients who had achieved clinical remission (no flares for ≥1 year, no tophi) with years of well-controlled uric acid levels, only 13% remained flare-free over 5 years 1
• 87% of patients experienced gout flares after stopping treatment
• Higher uric acid levels after stopping therapy correlated with more frequent and severe flares 1

The 2017 Treat-to-Target recommendations similarly emphasize that "long-term adherence to urate-lowering therapy is essential for an optimal outcome" as an overarching principle 2.

The Rationale: Gout is a Chronic Disease

Your normal uric acid level represents successful disease control, not disease cure. Think of this like managing hypertension or diabetes—the medication is working to keep your levels normal, but the underlying metabolic problem persists. Key points:

• Maintaining serum urate <6 mg/dL is mandatory to prevent urate crystal re-accumulation 1, 2
• Stopping therapy allows uric acid to rise again, triggering new crystal deposition
• This leads to recurrent flares, potential tophus formation, and joint damage 1

What the Evidence Shows About Stopping

The single case series examining ULT cessation demonstrated poor outcomes 1:

• Patients had been in remission with controlled uric acid for years before stopping
• Despite this optimal scenario, disease recurrence was nearly universal
• Patients with higher post-cessation uric acid levels had worse outcomes

Practical Considerations

Continue your current allopurinol dose that achieved your target uric acid level 1, 3. The FDA labeling and guidelines support:

• Maintaining the dose that successfully lowered your uric acid to <6 mg/dL
• Monitoring uric acid levels periodically (though specific intervals aren't rigidly defined)
• Continuing indefinitely as long as the medication is well-tolerated

Common Pitfall to Avoid

Do not stop allopurinol simply because you feel better and your uric acid is normal—this is the medication working as intended. Patient panels consistently expressed preference to continue treatment rather than risk return of symptoms, tophi, or joint damage 1.

When Might Stopping Be Considered?

The guidelines acknowledge this question but provide no scenario where stopping is clearly beneficial. Even in ideal candidates (no flares for years, normal uric acid, no tophi), the evidence shows stopping leads to disease recurrence in most patients 1.

The bottom line: Your normal uric acid level is the result of successful ongoing treatment, not a reason to stop it. Allopurinol should be continued indefinitely to maintain disease control and prevent the morbidity associated with recurrent gout 1, 2.